Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRT

IF 5.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Gaurav A. Upadhyay MD, FHRS , Marek Jastrzębski MD, PhD , Paul Foley MBChB, MDRes, FRCP , Badrinathan Chandrasekaran BSc, MD Res, FCRP , Zachary Whinnett MD, PhD, FHRS , Robert D. Schaller DO, FHRS , Rafał Gardas MD , Travis Richardson MD, FHRS , Pawel Moskal MD , D’Anne Kudlik MS , Robert W. Stadler PhD , Patrick Zimmerman PhD , James Burrell MS , Robert Waxman MS , Richard N. Cornelussen PhD , Jonathan Lyne MD , Bengt Herweg MD, FHRS , Pugazhendhi Vijayaraman MD, FHRS
{"title":"Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRT","authors":"Gaurav A. Upadhyay MD, FHRS ,&nbsp;Marek Jastrzębski MD, PhD ,&nbsp;Paul Foley MBChB, MDRes, FRCP ,&nbsp;Badrinathan Chandrasekaran BSc, MD Res, FCRP ,&nbsp;Zachary Whinnett MD, PhD, FHRS ,&nbsp;Robert D. Schaller DO, FHRS ,&nbsp;Rafał Gardas MD ,&nbsp;Travis Richardson MD, FHRS ,&nbsp;Pawel Moskal MD ,&nbsp;D’Anne Kudlik MS ,&nbsp;Robert W. Stadler PhD ,&nbsp;Patrick Zimmerman PhD ,&nbsp;James Burrell MS ,&nbsp;Robert Waxman MS ,&nbsp;Richard N. Cornelussen PhD ,&nbsp;Jonathan Lyne MD ,&nbsp;Bengt Herweg MD, FHRS ,&nbsp;Pugazhendhi Vijayaraman MD, FHRS","doi":"10.1016/j.hrthm.2025.04.026","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Traditional cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) may be less effective in patients with nonspecific intraventricular conduction delay (NIVCD). Left bundle branch area pacing (LBBAP) combined with left ventricular (LV) coronary venous lead pacing (LOT-CRT) may be more effective in these patients.</div></div><div><h3>Objective</h3><div>We assessed the echocardiographic response of LOT-CRT in patients with left bundle branch block (LBBB) or NIVCD and compared it with a propensity-matched BVP cohort.</div></div><div><h3>Methods</h3><div>Patients with conventional CRT indications and preferentially NIVCD were recruited. Echocardiographic parameters, including absolute percentage change in LV ejection fraction (LVEF) and relative percentage change in LV end-systolic volume (LVESV), were evaluated at implantation and 6-month follow-up. The BVP cohort was from an independent study, selected using 1:1 propensity-matching. LOT-CRT patients were subclassified into “successful LOT-CRT” (LBBAP; presence of r’ in electrode electrocardiography [ECG] V1) and “deep septal optimized therapy” (DOT-CRT) (functional deep septal capture).</div></div><div><h3>Results</h3><div>LOT-CRT patients (N = 34; age 64 years, women 38%, NIVCD 47%, LBBB 53%, implantable cardiac monitor 21%, QRSd 175 ms, and LVEF 27.6%) had significantly greater LVEF improvement (16.1% vs 6.1%; <em>P</em> &lt;.01) and LVESV reduction (−43.5% vs −20.9%; <em>P</em> &lt;.01) compared with BVP patients. After adjusting for baseline characteristics, LOT-CRT patients still had significantly greater LVEF improvement (7.5%; <em>P</em> &lt;.01) and LVESV reduction (18.4%; <em>P</em> &lt;.01) than BVP patients. The response was consistent across LBBB and NIVCD subgroups. LOT-CRT patients with QRS ≥ 171 ms showed greater benefit (<em>P</em> = .04; both LVEF and LVESV). No significant differences were observed between successful LOT-CRT and DOT-CRT.</div></div><div><h3>Conclusion</h3><div>LOT-CRT resulted in superior LVEF and LVESV improvements compared with BVP in NIVCD and LBBB patients and enhanced CRT response.</div></div>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":"22 10","pages":"Pages 2616-2624"},"PeriodicalIF":5.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1547527125023458","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Traditional cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) may be less effective in patients with nonspecific intraventricular conduction delay (NIVCD). Left bundle branch area pacing (LBBAP) combined with left ventricular (LV) coronary venous lead pacing (LOT-CRT) may be more effective in these patients.

Objective

We assessed the echocardiographic response of LOT-CRT in patients with left bundle branch block (LBBB) or NIVCD and compared it with a propensity-matched BVP cohort.

Methods

Patients with conventional CRT indications and preferentially NIVCD were recruited. Echocardiographic parameters, including absolute percentage change in LV ejection fraction (LVEF) and relative percentage change in LV end-systolic volume (LVESV), were evaluated at implantation and 6-month follow-up. The BVP cohort was from an independent study, selected using 1:1 propensity-matching. LOT-CRT patients were subclassified into “successful LOT-CRT” (LBBAP; presence of r’ in electrode electrocardiography [ECG] V1) and “deep septal optimized therapy” (DOT-CRT) (functional deep septal capture).

Results

LOT-CRT patients (N = 34; age 64 years, women 38%, NIVCD 47%, LBBB 53%, implantable cardiac monitor 21%, QRSd 175 ms, and LVEF 27.6%) had significantly greater LVEF improvement (16.1% vs 6.1%; P <.01) and LVESV reduction (−43.5% vs −20.9%; P <.01) compared with BVP patients. After adjusting for baseline characteristics, LOT-CRT patients still had significantly greater LVEF improvement (7.5%; P <.01) and LVESV reduction (18.4%; P <.01) than BVP patients. The response was consistent across LBBB and NIVCD subgroups. LOT-CRT patients with QRS ≥ 171 ms showed greater benefit (P = .04; both LVEF and LVESV). No significant differences were observed between successful LOT-CRT and DOT-CRT.

Conclusion

LOT-CRT resulted in superior LVEF and LVESV improvements compared with BVP in NIVCD and LBBB patients and enhanced CRT response.

Abstract Image

左束支区起搏优化心脏再同步化治疗(LOT-CRT)与传统CRT的超声心动图反应。
背景:传统的心脏再同步化治疗(CRT)与双心室起搏(BVP)可能对非特异性脑室传导延迟(NIVCD)患者效果较差。左束支区起搏(LBBAP)联合左室冠状静脉导联起搏(LOT-CRT)可能对这些患者更有效。目的:我们评估了左束支阻滞(LBBB)或NIVCD患者的LOT-CRT超声心动图反应,并与倾向匹配的BVP队列进行了比较。方法:选择常规CRT指征患者,优先选择NIVCD患者。超声心动图参数,包括左室射血分数(LVEF)的绝对百分比变化和左室收缩末期容积(LVESV)的相对百分比变化,在植入和6个月的随访中进行评估。BVP队列来自一项独立研究,采用1:1倾向匹配选择。LOT-CRT患者被细分为“成功的LOT-CRT”(LBBAP;电极心电图V1中r′的存在)和“DOT-CRT”(功能性深间隔捕获)。结果:LOT-CRT患者(N=34;年龄64岁,女性38%,NIVCD 47%, LBBB 53%, ICM 21%, QRSd 175 ms, LVEF 27.6%)患者的LVEF改善显著(16.1% vs 6.1%);结论:与BVP相比,NIVCD和LBBB患者的LVEF和LVESV改善更佳,并增强了CRT反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信